Hemispherx Biopharma Inc. Announces Updated Information about ME/CFS Expanded Access Program in the United States
Highlights Include Visit with Patients in North Carolina OCALA, Fla., Dec. 17, 2018 (GLOBE NEWSWIRE) — Hemispherx Biopharma, Inc. (NYSE […]